Gene | Input weight | Standard | Rank | |
MEF2C | 0.25 | 1 | 428 | |
MKL1 | - | - | 1703 | |
EDNRB | - | -1 | 2042 | |
NFATC3 | - | - | 2813 | |
MEF2A | - | - | 2837 | |
HEY2 | - | - | 3174 | |
NTF3 | 0.25 | 1 | 3232 | |
TSHZ3 | - | - | 3848 | |
FGF10 | - | -1 | 4532 | |
MYOCD | - | - | 5907 | |
ACVR1 | - | -1 | 6054 | |
BMP4 | - | -1 | 6499 | |
WNT7B | - | - | 7113 | |
CTNNB1 | 0.5 | 1 | 9066 | |
GATA6 | - | -1 | 10828 | |
AGT | - | -1 | 13305 | |
MESP1 | - | - | 13805 | |
TMEM204 | - | - | 15888 | |
WNT4 | - | - | 21809 |
GO:0051145
Name | Description | External IDs |
MEF2C | myocyte enhancer factor 2C | Entrez:4208  HGNC: 6996  Ensembl: ENSG00000081189  HPRD: 02809  |
MKL1 | megakaryoblastic leukemia (translocation) 1 | Entrez:57591  HGNC: 14334  HPRD: 10445  Ensembl: ENSG00000196588  |
EDNRB | endothelin receptor type B | Entrez:1910  Ensembl: ENSG00000136160  HPRD: 08834  HGNC: 3180  |
NFATC3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 | Entrez:4775  HGNC: 7777  Ensembl: ENSG00000072736  HPRD: 04077  |
MEF2A | myocyte enhancer factor 2A | Entrez:4205  Ensembl: ENSG00000068305  HGNC: 6993  HPRD: 02807  |
Geneset | Type | Freq. (Network vs Genome) | P-Value (FDR Corrected) | Genes |
Gene | Description | Avg. edge score to query | Rank | In geneset | In query |
MEF2C | myocyte enhancer factor 2C | ||||
MKL1 | megakaryoblastic leukemia (translocation) 1 | ||||
EDNRB | endothelin receptor type B | ||||
NFATC3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 | ||||
MEF2A | myocyte enhancer factor 2A |
Query gene | Gene | Gene description | Edge score |
MEF2C | MEF2C | myocyte enhancer factor 2C | |
MKL1 | MKL1 | megakaryoblastic leukemia (translocation) 1 | |
EDNRB | EDNRB | endothelin receptor type B | |
NFATC3 | NFATC3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 | |
MEF2A | MEF2A | myocyte enhancer factor 2A |